New drug duo tested in fight against advanced lung cancer
NCT ID NCT07111520
Summary
This study is testing a combination of two new drugs, called BNT326 and BNT327, for people with advanced non-small cell lung cancer (NSCLC). The main goals are to find safe doses and see if the combination can help shrink tumors or control the cancer's growth. It will enroll about 420 adults, including those who have tried other treatments and some who have not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Oncology, ARENSIA Exploratory Medicine
RECRUITINGChisinau, 2025, Moldova
-
NEXT Virginia
RECRUITINGFairfax, Virginia, 22031, United States
Conditions
Explore the condition pages connected to this study.